Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter

Gastrointestinal stromal tumour (GIST)

This page tells you about GIST. There is information about

 

What GIST is

GIST is a rare type of sarcoma found in the digestive system, most often in the wall of the stomach. Some GISTS are not cancerous (they are benign.) But they can become cancerous if not treated. Generally speaking, the larger the GIST, the more likely it is to be cancerous.

These tumours have a rather complicated name. Gastrointestinal means they start in the digestive system (the gastrointestinal tract). Stromal means they develop from tissues that support the connective tissues controlling the movements of the gut. Tumour means a lump or growth in the body.

About 6 out of 10 (60%) of these tumours start in the stomach. But they can begin anywhere in the digestive system, for example in the bowel or food pipe (oesophagus). Very rarely, they develop outside the gastrointestinal tract.

GIST are most common in people between 50 and 70 years old. We don't really know the cause but if you have the genetic condition called neurofibromatosis (NF) it can increase the risk of developing a GIST. Rarely, GIST can develop in children - there are about 20 cases a year in the UK.

 

Symptoms of GIST

People with early stage GIST often do not have any symptoms. So early stage GIST may be found when people are having tests for other medical conditions. Most GISTs are diagnosed in later stages of the disease. The symptoms of advanced GIST are likely to include

  • Pain or discomfort in the tummy (abdomen)
  • A feeling of fullness
  • Being sick
  • Blood in stools or vomit
  • Feeling very tired
  • A low red blood cell count (anaemia)

Other medical conditions apart from GIST can cause these symptoms. If you have these symptoms you should see your doctor. GIST is rare so they are more likely to be caused by something less serious, but it is always best to check.

 

Treatment for GIST

The most common treatment for GIST is surgery. This alone may cure small tumours. But it is less likely that a surgeon can completely remove a larger tumour. If GIST has spread to other parts of your body, your surgeon may be able to remove these secondary tumours too. 

Your surgeon removes the tumour and some tissue around it that doesn't contain any cancer cells. It depends on where your tumour is and how big it is, as to what surgery you'll need. To find information about surgery for where your cancer is go to our cancer types section and choose the part of the body the cancer is affecting. Then choose the surgery section for that type of cancer. 

For tumours in the stomach the surgeon will remove part or all of your stomach and may need to remove your spleen. There is information about stomach surgery in the stomach cancer section. After surgery you will need to adjust the amount you can eat at one time. You will probably have to eat small, frequent meals (about two hourly) for quite a long time after the operation. There is information about diet after stomach surgery in the coping with stomach cancer section. If your tumour is in your bowel you can find information about surgery in the bowel cancer section.

Chemotherapy and radiotherapy don't work well for GIST, so researchers have been looking for other types of treatment. You may have a biological therapy called Glivec (imatinib) to treat GIST that was not completely removed with surgery. Glivec is a tyrosine kinase inhibitor. This means it blocks a chemical (an enzyme) that the cancer needs in order to grow.

Your surgeon removes a sample of your tumour during your operation and sends it to the laboratory. A specialist tests the cells to confirm the diagnosis of GIST, and to see if the cells have a receptor on their surface called CD117. This CD117 protein is made by a gene called c-kit. A fault in this gene causes the c-kit gene to make too much CD117 protein.  Most GISTs have c-kit gene mutations.

If the GIST cells are CD117 positive, Glivec is likely to work very well. But it can work even for GISTs that are CD117 negative.

Glivec is a tablet. So you can have treatment at home. The National Institute for Health and Care Excellence (NICE) recommend that people have a dose of 400mg a day of imatinib (Glivec) for 12 weeks. After that, your specialist will arrange a CT scan to see if your GIST has responded to the treatment. In some cases, the GIST will disappear altogether. But to show a response to treatment, the GIST may not necessarily have shrunk. It may have become less dense. Your doctor may say it has become cystic. This means that there is fluid inside it, instead of solid tumour. Improvement in your symptoms is another way of telling that the treatment is working.

If the Glivec appears to be helping, you carry on treatment for another 12 weeks. Then your specialist checks again to see how the GIST has responded. You carry on having treatment until your GIST comes back, or shows signs of growing again.

You may also have Glivec to shrink a GIST before surgery, so that your surgeon can remove it more easily. Sometimes a surgeon can completely remove a GIST after treatment with Glivec. It may even be possible to remove GIST tumours that have spread to another part of the body, such as the liver.

If your GIST has grown or your symptoms have got worse, your specialist may recommend stopping Glivec because it isn't helping. NICE do not currently approve increasing the dose of Glivec, but this has been tested and there is some evidence that it may help.

A European trial is looking at whether Glivec (imatinib) can stop GISTs coming back after surgery to completely remove them. Having a treatment in addition to your main treatment is called adjuvant treatment. An American trial also looked into this and found that for 98 out of 100 people (98%) taking Glivec, the GIST stayed under control for at least 1 year, compared to 83 out of 100 people (83%) for those not taking Glivec. In August 2010 NICE decided not to recommend Glivec after surgery. The recommendations say that the people taking part in this research need to be monitored for longer to see how well it works. NICE will look at it again once the results of the European trial are available. In August 2010, the Scottish Medicines Consortium (SMC) said Glivec should be available within the NHS in Scotland for people who have CD117 positive GIST at high risk of coming back after surgery.

A drug, called sunitinib (Sutent) has been licensed in Europe to treat GIST if Glivec doesn't work, or stops working. You can have sunitinib for GIST if you either cannot take Glivec because of side effects or have GIST that has become resistant to it.  You must have GIST that cannot be completely removed or has spread.

A drug called regorafenib has been approved in the U.S for people with advanced GIST that cannot be removed with surgery or if Glivec and sunitinib are no longer working. Regorafenib has not been approved in Europe. 

 

Is GIST curable?

If GIST can be completely removed with surgery, then it may be cured. As with any cancer, there is a chance that the tumour could come back. Because of this risk, you will have regular check ups with your specialist for some time after your surgery. It is best that you talk to your own specialist about whether there is a risk of GIST returning, as the circumstances will be different for each person.

Since the discovery of Glivec, people with GIST that cannot be completely removed are doing much better. Unfortunately, specialists don't think it is a complete cure. How people respond to particular drugs will always vary, depending on all their individual circumstances. But generally, Glivec stops GIST from growing for around 2 years. Even if the GIST comes back, Glivec may still help to slow down the growth of the tumour and may help to control it for another few years. As Glivec is a relatively new treatment, we don't have the full picture as yet. According to our specialist advisors, the longest survivors are approaching 8 years of Glivec treatment, with no sign of their GIST returning. There is research to find out the best treatment for people to have after Glivec stops working.

 

Where to find more information

We have a whole section on soft tissue sarcomas and some of that information may be useful to you. There are other useful organisations listed on our sarcoma organisations and sarcoma links pages. In particular, you are likely to find GIST Support UK of help. This is an organisation of people with GIST and their families. Their website has lots of useful information.

Rate this page:
Submit rating

 

Rated 5 out of 5 based on 146 votes
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team

No Error

Updated: 24 February 2014